Suraksha Diagnostic reported FY26 consolidated revenue of ₹3,104.14 million, a 23% YoY increase, with EBITDA of ₹985.58 million.
The company added 20 centers since its December 2024 listing and completed the strategic acquisition of Fetomat Wellness for ₹38.80 million.
Management provided an investor presentation detailing Q4 and FY26 audited results ahead of an earnings call scheduled for 22 May 2026.
Key operational metrics include 68 centers, 8 laboratories, serving 1.37 million patients with an average revenue per patient of ₹2,264.